Showing results (151-160 of 370) with videos related to
Sort By:
Pageof 37
Urologie (Heidelberg, Germany)|March 25, 2026
[Pharmacotherapy of benign prostatic syndrome : Medications, innovations and future prospects]P Keller, Alexander Tamalunas, Michael Atzler, et al.BJU International|September 24, 2013
Bladder function in a cannabinoid receptor type 1 knockout mouseClaudius Füllhase, Lysanne Campeau, Andrei Sibaev, et al.The Prostate|October 11, 2021
Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983Ru Huang, Yuhan Liu, Bingsheng Li, et al.Gastroenterology|March 15, 2006
Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic ratsMartin Hennenberg, Erwin Biecker, Jonel Trebicka, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|June 13, 2012
Specificity evaluation of antibodies against human β3-adrenoceptorsHana Cernecka, Peter Ochodnicky, Wouter H Lamers, et al.Pharmacology & Therapeutics|May 1, 2016
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal diseaseMartin C Michel, Hans R Brunner, Carolyn Foster, et al.BMC Gastroenterology|June 20, 2020
Impact of guideline awareness in public pharmacies on counseling of patients with acute or chronic constipation in a survey of pharmacy personnelMarion Eberlin, Sabine Landes, Doerthe Biber-Feiter, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|April 10, 2008
Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?Martin C Michel, Eric Fliers, Cornelis J F Van NoordenBasic Research in Cardiology|March 21, 2007
Pitfalls in the normalization of real-time polymerase chain reaction dataMariëlle C Hendriks-Balk, Martin C Michel, Astrid E AlewijnseBritish Journal of Pharmacology|October 27, 2004
Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolitesAstrid E Alewijnse, Stephan L M Peters, Martin C MichelPageof 37